Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism

No abstract is available for this paper.

• Publication year

  1999

• Venue

  FEBS Letters

• Publication date

  1999-10-29

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-5793(99)01364-2PMID 10544257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interindividual variability of coumarin 7-hydroxylation in a Turkish population

  2004cited by this paper
• Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine

  2004cited by this paper
• Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method.

  1999cited by this paper
• The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP.

  1999cited by this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer.

  1999cited by this paper
• Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population

  1999cited by this paper
• Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes

  1999cited by this paper
• CYP2A6 gene deletion reduces susceptibility to lung cancer.

  1999cited by this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer

  1999cited by this paper
• Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.

  1999cited by this paper
• A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans.

  1999cited by this paper
• Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6

  1998cited by this paper
• Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase

  1998cited by this paper
• Nicotine metabolism defect reduces smoking

  1998cited by this paper
• Molecular genetics of congenital adrenal hyperplasia (21‐hydroxylase deficiency): implications for diagnosis, prognosis and treatment

  1998cited by this paper
• A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.

  1997cited by this paper
• Individual differences in nicotine kinetics and metabolism in humans.

  1997cited by this paper
• CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis.

  1997cited by this paper
• A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.

  1997cited by this paper
• A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes.

  1997cited by this paper
• Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations.

  1996cited by this paper
• Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.

  1996cited by this paper
• Nomenclature for human CYP2D6 alleles.

  1996cited by this paper
• Role of human cytochrome P4502A6 in C-oxidation of nicotine.

  1996cited by this paper
• A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.

  1995cited by this paper
• High yield expression of functionally active human liver CYP2D6 in yeast cells.

  1995cited by this paper
• Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19

  1995cited by this paper
• Chimeras of the human cytochrome P450 1A family produced in yeast. Accumulation in microsomal membranes, enzyme kinetics and stability.

  1994cited by this paper
• Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5.

  1993cited by this paper
• Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells.

  1993cited by this paper
• Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.

  1992cited by this paper
• Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.

  1992cited by this paper
• Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine.

  1992cited by this paper
• Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences.

  1992cited by this paper
• Purification and characterization of human liver microsomal cytochrome P-450 2A6.

  1991cited by this paper
• The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.

  1990cited by this paper
• Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cells.

  1990cited by this paper
• A simple and sensitive assay of 7-ethoxycoumarin deethylation.

  1978cited by this paper
• THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

  1964cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Impact of POR and Cytochrome b5 Variability on the Genotype-Phenotype Discordance of CYP2A6 and CYP2D6: A Quantitative Analysis in Chinese Human Livers

  2026cites this paper
• Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing

  2025cites this paper
• Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants

  2024cites this paper
• CIGARETTE SMOKING AND INTRACRANIAL ANEURYSMS: A PILOT ANALYSIS OF SNPs IN THE CYP2A6 GENE IN THE ITALIAN POPULATION.

  2023cites this paper
• Understanding genetics and genetic polymorphism in tobacco cessation: A public health perspective

  2022cites this paper
• Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer

  2020cites this paper
• Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense

  2020cites this paper
• Association between CYP2A6 genotypes and smoking behavior in Lebanese smokers

  2020cites this paper
• Enzyme Polymorphisms Affecting Xenobiotic Toxicity

  2020cites this paper
• Cancer Hazard Identification Integrating Human Variability: The Case of Coumarin

  2019cites this paper
• Genetically determined metabolism of nicotine and its clinical significance.

  2019cites this paper
• Genetic Polymorphism of CYP2A6 and Its Relationship with Nicotine Metabolism in Male Bataknese Smokers Suffered from Lung Cancer in Indonesia

  2018cites this paper
• Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population

  2018cites this paper
• Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis

  2018cites this paper
• Functional Characterization of 34 CYP2A6 Allelic Variants by Assessment of Nicotine C-Oxidation and Coumarin 7-Hydroxylation Activities

  2017cites this paper
• Variation in CYP2A6 Activity and Personalized Medicine

  2017cites this paper
• Title Comprehensive evaluation of variability in nicotine metabolism andCYP 2 A 6 polymorphic alleles in four ethnic populations

  2017cites this paper
• CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients

  2017cites this paper
• Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction

  2017influential citation
• Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers.

  2016cites this paper
• Role of pharmacogenetics for the improvement of cancer treatment

  2016cites this paper
• Genetic polymorphisms and phenotypic analysis of CYP 2 A 6 in the Sherpa population

  2016cites this paper
• The allele frequency of CYP2A6*4 in four ethnic groups of China.

  2015cites this paper
• Is there evidence for potential harm of electronic cigarette use in pregnancy?

  2015cites this paper
• Combinations of CYP2A6*4 and Glutathione S-Transferases Gene Polymorphisms Modify the Association Between Maternal Secondhand Smoke Exposure During Pregnancy and Small-for-Gestational-Age.

  2015cites this paper
• Association analysis of CYP2A6 polymorphism to sudden and unexpected death of infants

  2015cites this paper
• Genotyping of wild-type cytochrome P450 2A6 and whole-gene deletion using human blood samples and a multiplex real-time polymerase chain reaction method with dual-labeled probes.

  2015cites this paper
• CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.

  2015cites this paper
• Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers.

  2015cites this paper
• CYP450 and Ethnicity

  2014cites this paper
• The Pharmacogenetics of Nicotine Dependence and Smoking Cessation Therapies

  2014cites this paper
• Identification and Characterization of Novel CYP2A6 Variants in African American Slow Nicotine Metabolizers

  2014cites this paper
• High CYP2A6 Enzyme Activity as Measured by a Caffeine Test and Unique Distribution of CYP2A6 Variant Alleles in Ethiopian Population

  2014influential citation
• The Interaction Between Genetics and Tobacco Consumption in Light Smokers

  2014cites this paper
• The Effect of Menthol on Nicotine Metabolism: a Cross Species Evaluation

  2013cites this paper
• Cytochrome P450 Metabolism of Betel Quid-Derived Compounds: Implications for the Development of Prevention Strategies for Oral and Pharyngeal Cancers

  2013cites this paper
• CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis

  2013cites this paper
• Association of CYP2A6*4 with Susceptibility of Lung Cancer: A Meta-Analysis

  2013cites this paper
• Comparisons of CYP2A6 genotype and enzyme activity between Swedes and Koreans.

  2013cites this paper
• Metabolism of 7‐ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants

  2013cites this paper
• Advances in molecular modeling of human cytochrome P450 polymorphism.

  2013cites this paper
• Relationship Between Amounts of Daily Cigarette Consumption and Abdominal Obesity Moderated by CYP2A6 Genotypes in Chinese Male Current Smokers

  2012influential citation
• Nicotine Metabolism and its Implications

  2012cites this paper
• PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6

  2012cites this paper
• Cytochrome P450 variations in different ethnic populations

  2012cites this paper
• Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35).

  2012cites this paper
• Gene, ethnic and gender influences predisposition of adverse drug reactions to artesunate among Malaysians

  2012cites this paper
• [Relation of genetic variants of CYP2A6 with tobacco dependence and smoking habit in Chilean subjects. A pilot study].

  2012cites this paper
• Importance of pharmacogenetic and environmental factors for variation in caffeine disposition: with special emphasis on CYP1A2, CYP2A6, NAT2 and XO

  2012cites this paper
• PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8

  2012cites this paper
• Genetic Variations in Metabolizing Enzymes

  2012cites this paper
• Genetics of Drug Disposition

  2012cites this paper
• Genetic polymorphisms of drug‐metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population

  2012cites this paper
• Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.

  2012cites this paper
• Associations of CYP2A6 genotype with smoking behaviors in southern China.

  2011cites this paper
• Genetic vulnerability and susceptibility to substance dependence.

  2011cites this paper
• CYP2A6 and CYP2B6 Genetic Variation, and Tobacco Use Behaviours and Biomarkers in Alaska Natives

  2011influential citation
• Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations

  2011cites this paper
• Genetic Vulnerability and Susceptibility to Substance Dependence

  2011cites this paper
• Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes

  2011cites this paper
• Pharmacogenomics of Maternal Tobacco Use: Metabolic Gene Polymorphisms and Risk of Adverse Pregnancy Outcomes

  2010cites this paper
• In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population

  2010cites this paper
• The Impact of CYP2A6 Genotype on Smoking Cessation in an Extended Nicotine Patch Therapy Clinical Trial

  2010cites this paper
• An investigation of nicotine metabolism in mice : the impact of pharmacological inhibition and genetic influences on nicotine pharmacology.

  2010cites this paper
• The genetic aspects of nicotine metabolism and their impact on adolescent nicotine dependence

  2010cites this paper
• An Introduction to Metabolic Reaction Phenotyping

  2010cites this paper
• Epigenetics and reproduction and the developmental origins of health and disease

  2010cites this paper
• Molecular genetics of nicotine metabolism.

  2009cites this paper
• 2 Humans 2 . 1 Human Nicotine Metabolism

  2009cites this paper
• Environmental Influences on Epigenetic Profiles

  2009cites this paper
• In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

  2009cites this paper
• Structure, function, regulation and polymorphism of human cytochrome P450 2A6.

  2009cites this paper
• Polymorphism of human cytochrome P450 enzymes and its clinical impact

  2009influential citation
• Gene–gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population

  2009cites this paper
• High prevalence of CYP2A6*4 and CYP2A6*9 alleles detected among a Malaysian population.

  2009influential citation
• A Bioinformatics Approach for the Phenotype Prediction of Nonsynonymous Single Nucleotide Polymorphisms in Human Cytochromes P450

  2009cites this paper
• Polymorphic drug metabolism in anaesthesia.

  2009cites this paper
• Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms.

  2008cites this paper
• Genetic polymorphisms of CYP2A6 affect the in-vivo pharmacokinetics of pilocarpine

  2008cites this paper
• CYP2A6 polymorphisms and risk for tobacco-related cancers.

  2008cites this paper
• Analysis of copy number variation in the rhesus macaque genome identifies candidate loci for evolutionary and human disease studies.

  2008influential citation
• Untersuchung der Nikotinkinetik in Abhängigkeit von biologischen und rauchanamnestischen Variablen

  2008cites this paper
• Identification of Novel CYP2A6*1B Variants: The CYP2A6*1B Allele is Associated With Faster In Vivo Nicotine Metabolism

  2008cites this paper
• Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.

  2007cites this paper
• Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants.

  2007cites this paper
• Past and Future Applications of CYP450-Genetic Polymorphisms for Biomonitoring of Environmental Toxicants

  2007cites this paper
• Cytochrome P450: another player in the myocardial infarction game?

  2007cites this paper
• Racially classified social group tobacco-related health disparities: what is the role of genetics?

  2007cites this paper
• Polymorphisms of GSTP 1 and GSTT 1 , but not of CYP 2 A 6 , CYP 2 E 1 or GSTM 1 , modify the risk for esophageal cancer in a western population

  2007cites this paper
• Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.

  2007cites this paper
• Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.

  2007cites this paper
• Retinal toxic reactions following photopheresis.

  2007cites this paper
• A Novel Duplication Type of CYP2A6 Gene in African-American Population

  2007cites this paper
• Characterization of Orphan Human Cytochromes P450

  2007cites this paper
• Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.

  2007cites this paper
• The pharmacogenetics of cytochrome P450 enzymes in personalized medicine

  2007cites this paper
• Genetic Influences on Smoking Behavior and Nicotine Dependence: a Review

  2007cites this paper
• Characterization of the Novel Defective CYP2C9*24 Allele

  2007cites this paper
• Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations

  2006cites this paper
• CYP2A6 polymorphisms in Malays, Chinese and Indians

  2006influential citation